Category Medicine and Healthcare
Press Release
Jaguar Health Announces Extension of the Maturity Date of its Convertible Promissory Notes from Recently Closed Bridge Financing to January 30, 2026
Company's CEO, board members, other C-suite members, and institutional and accredited investors are participants in the extension of the bridge financing Read More
Press Release
Ainos and Kenmec Launch Strategic Partnership to Deploy AI-Powered Scent Intelligence in Smart Factories Across Asia
AI Nose and SLM SmellTech platform enter scale-up phase targeting robotics, automation, and environmental sensing markets Kenmec and Ainos to show case AI Nose and SLM in Automation Taipei 2025 in August Read More
Press Release
DEA's Last MARIJUANA Gamble: Unconstitutional ALJ System Collapses as MMJ BioPharma Fights Back
The Stakes Couldn't Be Higher This is more than a marijuana case. It's a constitutional case. It's a test of whether the DEA is still accountable to the courts, to the people, and to the law. "If the DEA believes it can ignore the Supreme Court, then no American is safe from administrative tyranny," Duane Boise warned. " MMJ will fight. And we will win." Read More
Press Release
Black Book Releases 2025 Rankings of Top Patient Financial Engagement Solutions as Health Systems Prioritize Billing Transparency and Payment Innovation
RevSpring, CarePayment, and Knowtion Health Recognized for Excellence in Patient Financial Technologies in Rankings Announced Today at HFMA ANI Conference Read More
Press Release
2025's Top-Rated Claims Management RCM Software Vendors Announced at HFMA ANI by Black Book
Rankings unveiled at HFMA Annual National Institute in Denver spotlight leading software solutions for Clearinghouse, Denial Management, and Claim Adjudication across hospitals and physician organizations Read More
Press Release
From Rural Hospitals to Academic Health Systems: 2025's Best End-to-End RCM Vendors Ranked by Client Satisfaction & Performance, Black Book User Survey
Healthcare Finance Leaders Identify Top Software Solutions Across U.S. Hospital Segments Based on Real-World Results, ROI, and Financial Outcomes Read More
Press Release
Jaguar Health Provides Updates on Orphan Disease Intestinal Failure Development Program for Crofelemer
Enrollment in company's first-of-its-kind placebo-controlled Phase 2 study to evaluate the efficacy of crofelemer for microvillus inclusion disease (MVID) in pediatric patients has reached approximately 25% As recently announced, initial proof-of-concept results of the ongoing investigator-initiated trial (IIT) show crofelemer reduced the required total parenteral nutrition in patients with intestinal failure due to MVID and short bowel syndrome by up to 27% and 12.5% respectively; data from the third patient enrolled is expected Company strategy: Seek business development partnerships for license to develop and commercialize Jaguar's intestinal failure products, resulting in non-dilutive funding for Jaguar Read More
Press Release
Aytu BioPharma Expands and Extends Lending Agreement with Eclipse Following Agreement to Commercialize First-in-Class Antidepressant EXXUA(TM)
Term loan maturity extended by 12 months to June 2029 Principal balance on term loan expanded to $13.0 million from $11.1 million currently Expanded revolving line of credit facility by $1.5 million Expanded facilities allow for added working capital flexibility as commercial launch of EXXUA is anticipated to occur in the fourth calendar quarter of 2025 Read More
Press Release
DEA Blocks MMJ FDA Cannabis Research While Tribal Marijuana Transit Networks Operate in N.C. Unchecked
Watch the Senate hearing: https://dai.ly/x9j0le4 Despite MMJ's full regulatory compliance and orphan drug status from the FDA, its DEA manufacturing registration (GROW MARIJUANA) remains stonewalled inside a DEA administrative court system now deemed unconstitutional under Axon and Jarkesy. Meanwhile, tribal transit networks face virtually no enforcement-exposing a hypocritical and dangerous DEA double standard. Read More
Press Release
DEA Judge Mulrooney’s MMJ Marijuana Ruling May Be DEA’s Last Stand Before the Constitution Strikes Back
Judge Mulrooney's decision may have handed MMJ BioPharma Cultivation a defeat inside the DEA's walls, but in doing so, he may have handed MMJ a powerful victory in federal court. The record of constitutional violations and DEA violations is now preserved - the "Axon-Jarkesy defense"is primed - and the very administrative law judge system the DEA clings to may not survive scrutiny. Read More
Press Release
Vision Hero Introduces Clinically Researched Eye Support Formula for Digital Age Wellness in 2025
Featuring lutein, zeaxanthin, alpha-lipoic acid, and quercetin, Vision Hero offers multi-pathway nutritional support for macular health, digital eye strain, and age-related visual changes. Read More
Press Release
Lung Clear Pro Positioned as Part of 2025’s Respiratory Resilience Movement Amid Allergy & Air Quality Concerns
Herbal liquid formula with mullein, eucalyptus, and cordyceps supports mucus clearance, deeper breathing, and restful sleep as part of a proactive approach to modern respiratory wellness in 2025. Read More
Press Release
Lipidene Reveals Mediterranean-Based Cholesterol Support Supplement Ahead of 2025 Wellness Trends
Clinically dosed with standardized bergamot and hydroxytyrosol, the new Lipidene supplement offers a natural approach to lipid health and heart support aligned with 2025 wellness trends. Read More
Press Release
Vyvamind Supplement Report: Ingredient-by-Ingredient Breakdown of the 2025 Focus Formula
New report analyzes the clean nootropic formulation behind Vyvamind, detailing how each scientifically-backed ingredient supports mental clarity, focus, and sustainable cognitive performance in 2025. Read More
Press Release
Retransmission - Dr. Meegan Gruber Shares Insight on Plastic Surgery Transparency: How Younger Generations Are Shaping a New Era of Body Authenticity
A culture change is affecting how people talk about cosmetic surgery, from popular TikToks to BBL reversals. Dr. Meegan Gruber shows why choices made with knowledge and power are becoming more critical. Read More
Press Release
BloodVitals Device Offers Pain-Free, Needle-Free Glucose Monitoring With Medical-Grade Accuracy
The FDA-cleared BloodVitals device leverages advanced optical sensor technology to deliver instant blood sugar, pulse, and oxygen readings-without skin penetration, test strips, or daily discomfort. Read More
Press Release
Aptevo Expands Differentiated CD3 Portfolio with APVO455, Advancing a Suite of Targeted T-cell Engagers
Mipletamig-driven clinical validation of the CRIS-7 derived CD3-binding domain underpins Aptevo's expansion from hematologic to solid tumors New candidate APVO455 targets Nectin-4+ cancers, joins mipletamig (AML) and APVO442 (prostate) in Aptevo's tumor-directed CD3 suite Read More
Press Release
LuminEye Nano-Drops Introduced as Vision Support Formula for Blurry Vision, Floaters, and Night Clarity
Formulated with antioxidant-rich nutrients and nano-delivery technology, LuminEye aims to support visual clarity, eye hydration, and night vision comfort without synthetic additives. Read More
Press Release
Valneva Selects CliniOps as the Technology Partner for Multiple Post-Marketing Studies to Support the IXCHIQ Chikungunya Vaccination Program in Brazil
This collaboration underscores CliniOps' continued mission to transform clinical research through smart technologies, enabling equitable access, operational efficiency, and robust data quality, even in hard-to-reach geographies. Read More
Press Release
DEA Judge Mulrooney Rules on Marijuana Growers Case, Exposing Systemic Bias Against Cannabis Research
Judge Mulrooney's ruling epitomizes the DEA's institutional resistance to cannabis reform, prioritizing bureaucratic obstruction over public health and constitutional rights. As MMJ fights back in federal court, the case exposes a system rigged against progress-one where patients, science, and fairness are collateral damage in the failed DEA war on marijuana research. Read More
Press Release
iGenics Vision Wellness Supplement Offers Natural Macular Support With Science-Backed Ingredients
Formulated with lutein, zeaxanthin, bilberry, and saffron, the plant-based iGenics supplement delivers targeted nutritional support for digital eye strain, blue light exposure, and long-term macular wellness. Read More
Press Release
HealthRX Introduces Overnight Access to Ozempic and GLP-1 Medications-No Insurance Needed
HealthRX's direct-access platform eliminates insurance roadblocks by offering overnight delivery of doctor-prescribed GLP-1 weight loss medications like Ozempic® and semaglutide-backed by licensed physicians, transparent pricing, and real results. Read More
Press Release
Telomir Pharmaceuticals Prevents Cellular Aging in Patient-Derived Cells from Children with Progeria - an Ultra-Rare Genetic Disorder that Causes Rapid Aging
Study used cell lines obtained from the Progeria Research Foundation to evaluate Telomir-1's effects on key drivers of accelerated aging Read More
Press Release
Mipletamig Demonstrates Compelling Clinical Activity in Frontline AML
85% remission rate observed in evaluable frontline AML patients Mipletamig combination enables rare pathway to transplant in a previously ineligible unfit patient No dose-limiting toxicities observed among evaluable patients; safety profile remains strong Evidence mounts for mipletamig as a potentially transformational addition to standard of care in frontline AML as targeted CD123 x CD3 approach showing power and precision, limited added toxicity Mipletamig Trial Momentum Builds as Cohort 3 Nears Full Enrollment at highest dose level evaluated to date in combination therapy Read More
Press Release